Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.52 |
| ▸ | PGK2 | P07205 | 1/20 | 0.52 |
| ▸ | PGD | P52209 | 3/20 | 0.48 |
| ▸ | MPI | P34949 | 1/20 | 0.48 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6655023 | 1.00 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL14278848 | 1.00 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7341 | 1.00 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7340 | 1.00 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL14278847 | 1.00 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| Selenium SCHEMBL7630839 | 0.98 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL468639 | 0.98 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL11313373 | 0.98 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL1134754 | 0.98 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| Water SCHEMBL11070947 | 0.98 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120530909-B | Early breeding and evaluating method for salt tolerance of grass carp based on serum metabolic markers | 中国水产科学研究院淡水渔业研究中心 | 2026-05-19 | — | — | CN | claimed |
| WO-2026098635-A1 | NEW CATIONIC LIPID WITH NITROGEN-CONTAINING HETEROCYCLIC HEAD GROUP AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| WO-2026098601-A1 | LIPID NANOPARTICLE FOR DELIVERING LOAD | 北京剂泰生命科技有限公司 | 2026-05-15 | — | — | WO | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| CN-119998259-A | Lipid structures and compositions comprising the same | 特恩生物技术公司 | 2025-05-13 | — | — | CN | claimed |
| WO-2025092756-A1 | LIPID COMPOUND AND COMPOSITION THEREOF | GUANGZHOU RIBOBIO CO., LTD. (CN) | 2025-05-08 | — | — | WO | claimed |
| CN-119874553-A | Lipid compounds and lipid nanoparticles for delivery | 仁景(苏州)生物科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119874554-A | Lipid compounds and lipid nanoparticles for delivery | 仁景(苏州)生物科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119874661-A | Lipid compounds and lipid nanoparticle compositions | 仁景(苏州)生物科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119654167-A | Nucleic acid compositions comprising amphiphilic oligoethylene glycol (OEG) conjugated compounds and methods of using such compounds and compositions | 生物技术公司 | 2025-03-18 | — | — | CN | claimed |
| EP-1404706-A2 | MYCOBACTERIAL ANTIGENS EXPRESSED DURING LATENCY | Health Protection Agency (GB) | 2004-04-07 | — | — | EP | claimed |
| EP-1003567-B1 | TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS | BIOSYNTECH CANADA INC (CA) | 2003-08-06 | — | — | EP | claimed |
| EP-1314033-A2 | IMMOBILISED PHOSPHATIDIC ACID PROBE | THE BABRAHAM INSTITUTE (GB) | 2003-05-28 | — | — | EP | claimed |
| WO-2003004520-A2 | MYCOBACTERIAL ANTIGENS EXPRESSED DURING LATENCY | HEALTH PROTECTION AGENCY (GB) | 2003-01-16 | — | — | WO | claimed |
| EP-1229940-A1 | TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION | BIO SYNTECH CANADA INC. (CA) | 2002-08-14 | — | — | EP | claimed |
| WO-2002018946-A2 | IMMOBILISED PHOSPHATIDIC ACID PROBE | THE BABRAHAM INSTITUTE (GB) | 2002-03-07 | — | — | WO | claimed |
| WO-2001036000-A1 | TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION | BIO SYNTECH CANADA, INC. (CA) | 2001-05-25 | — | — | WO | claimed |
| EP-0473435-B1 | Mono-N,N-dimethyl-4-aminopyridinium sn-glycerol-3-phosphate, production and use thereof in preparation of phosphatidic acids | GENZYME CORP (US) | 1995-07-19 | — | — | EP | claimed |
| US-5162535-A | Mono-N,N-dimethyl-4 aminopyridinium sn-glycerol-3-phosphate, its production and use in preparation of phosphatidic acids | GENZYME CORPORATION (US) | 1992-11-10 | — | — | US | claimed |
| EP-0473435-A1 | Mono-N,N-dimethyl-4-aminopyridinium sn-glycerol-3-phosphate, production and use thereof in preparation of phosphatidic acids | GENZYME CORPORATION (US) | 1992-03-04 | — | — | EP | claimed |